🌍·1d agoResearch
The real-world safety evaluation of the selective NaV1.8 inhibitor suzetrigine: disproportionality analysis and flexible empirical bayes signals from FAERS with external triangulation
Publisher
E
Europe PMC
EU
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Europe PMC
- Region
- EU
- Scope
- Research
- Published
- June 26, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on europepmc.org
Leave the platform to read the original full article on the publisher site.
Source: Europe PMC
Scope: Research
Related coverage
More related coverage
Europe PMC/15h ago
The Italian landscape of digital therapeutics in a European context
Europe PMC/15h ago
Pharmacological Characterization of SLL-022CCP, a Selective κ‑Opioid Receptor Agonist with Potent Antinociceptive Effects and Low Central Side Effects
Europe PMC/15h ago
Next-generation TREM2-targeted therapies for Alzheimer's disease: insights and directions from the INVOKE-2 trial
Crossref/15h ago